The newly patented focuses on generative AI technology designed for dynamic data retrieval, autonomous summary generation, decisioning and automated actions across systems. It combines with Ensemble’s Notes Wizard to automate accurate data exchange between hospital systems, including the EHR. The technology can adapt to shifting payer behavior for improved automation and already has automated actions on around 25% of transactions in targeted categories.
Ensemble aims to maximize human intelligence by combining it with AI, and will continue customizing the technology for unique healthcare provider circumstances to maximize every patient interaction and operational transaction. The boost is particularly beneficial in the denial appeal process.
“Appealing denials from payers has become so resource-intensive that many providers are abandoning the process entirely, resigning themselves to accepting reimbursement far below the value of the care they deliver and the costs outlined in their managed care contract,” said Judson Ivy, founder and CEO of Ensemble, in a news release. “Through this latest innovation, we’re helping providers combat unnecessary denials by justifying care decisions quickly and effectively at scale to alleviate that burden and ensure accurate, prompt payment so they can focus on delivering care and world-class patient experiences, not defending it.”
Ensemble manages $37 billion in annual net patient revenue and partners with health systems across the U.S. for improved revenue cycle and patient experience performance with end-to-end managed services.
